United-Guardian, Inc.  

(Public, NASDAQ:UG)   Watch this stock  
Find more results for UG
0.00 (0.00%)
Real-time:   3:56PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 19.00 - 35.25
Open     -
Vol / Avg. 0.00/5,287.00
Mkt cap 96.30M
P/E 22.05
Div/yield 0.32/3.82
EPS 0.95
Shares 4.60M
Beta 0.11
Inst. own 17%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 16.35% 38.29%
Operating margin 21.61% 54.30%
EBITD margin - 48.59%
Return on average assets 10.38% 40.01%
Return on average equity 11.30% 43.61%
Employees 33 -
CDP Score - -


230 Marcus Blvd.
United States - Map
+1-631-2730900 (Phone)
+1-631-2730858 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


United-Guardian, Inc. (United), through its Guardian Laboratories Division (Guardian), manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical and health care products, and specialty industrial products. The Company also conducts research and development, primarily related to the development of cosmetic and personal care products. The Company�s products are into four product categories: pharmaceuticals, personal care products (including cosmetic ingredients), medical products, and industrial products. The Company�s two product lines are the LUBRAJEL line of cosmetic ingredients and medical lubricants, which accounted for approximately 82% of the Company's sales during the year ended December 31, 2011, and its RENACIDIN IRRIGATION (RENACIDIN), a pharmaceutical product that accounted for approximately 13% of its sales during 2011. The Company's products are marketed through collaborative agreements with larger companies.

Officers and directors

Kenneth H. Globus Chairman of the Board, President, General Counsel
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert S. Rubinger Chief Financial Officer, Executive Vice President, Treasurer, Secretary, Director
Age: 71
Bio & Compensation  - Reuters
Peter A. Hiltunen Vice President
Age: 55
Bio & Compensation  - Reuters
Joseph J. Vernice Vice President, Manager - Research and Development, Director - Technical Services
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Roseann LaCorte Controller
Age: 47
Bio & Compensation  - Reuters
Andrew A. Boccone Independent Director
Age: 68
Bio & Compensation  - Reuters
Arthur M. Dresner Independent Director
Age: 72
Bio & Compensation  - Reuters
Lawrence F. Maietta Independent Director
Age: 56
Bio & Compensation  - Reuters
Christopher W. Nolan Sr. Independent Director
Age: 49
Bio & Compensation  - Reuters